Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Newmont Corp.

Start price
Target price
Perf. (%)
€31.80
07.03.24
€32.00
07.03.25
4.40%
28.03.24

Standard Investments for future growth
Capable Management
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€7.72
05.01.24
€13.65
05.01.25
85.88%
28.03.24

buy
Cloudflare Inc.

Start price
Target price
Perf. (%)
€74.58
30.12.23
€80.00
30.12.24
19.76%
28.03.24

Could be worthwhile Investment >10% per year
buy
Transmedics Group Inc

Start price
Target price
Perf. (%)
€56.85
07.11.23
€65.42
07.11.24
21.37%
28.03.24

buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€8.24
08.08.23
€12.78
08.08.24
74.15%
28.03.24

buy
Sciplay Corp

Start price
Target price
Perf. (%)
€18.00
03.08.23
€21.04
03.08.24
20.00%
20.11.23

buy
Hims & Hers Health Inc.

Start price
Target price
Perf. (%)
€7.80
28.07.23
€9.99
28.07.24
83.97%
28.03.24

buy
Astria Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.86
20.07.23
€10.00
30.04.26
40.18%
26.03.24

Could be very worthwhile Investment >20% year
Antelope Enterprise Hldgs Ltd.

Start price
Target price
Perf. (%)
€0.58
14.07.23
€0.30
14.07.24
-51.72%
20.11.23

Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Oric Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.70
26.06.23
€9.00
31.12.25
74.03%
21.03.24

Could be very worthwhile Investment >20% year
buy
Equillium Inc.

Start price
Target price
Perf. (%)
€0.64
24.06.23
€1.10
24.06.24
201.25%
28.03.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Risky balance sheet
buy
Ideaya Biosciences Inc.

Start price
Target price
Perf. (%)
€22.20
24.06.23
€37.00
31.12.25
77.48%
28.03.24

Could be very worthwhile Investment >20% year
buy
Merus N.v.

Start price
Target price
Perf. (%)
€23.20
24.06.23
€40.00
30.04.26
72.41%
28.03.24

Could be very worthwhile Investment >20% year
buy
Centessa Pharmaceuticals Plc

Start price
Target price
Perf. (%)
€5.80
24.06.23
€9.00
31.12.25
68.10%
28.03.24

Could be very worthwhile Investment >20% year
buy
Jumia Technologies AG

Start price
Target price
Perf. (%)
€2.58
28.05.23
€3.00
28.05.24
85.66%
28.03.24

Good rating
Standard Investments for future growth
High valuation
Very low/no dividend yield expected
Lumaland AG

Start price
Target price
Perf. (%)
€2.53
06.05.23
€2.00
02.05.24
-98.92%
28.03.24

EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Risky Investment